Evidence map›Paper›PMID 31575335›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2020

Test-retest repeatability of [

Tessa Timmers, Rik Ossenkoppele, Denise Visser, Hayel Tuncel, Emma E Wolters, Sander Cj Verfaillie, Wiesje M van der Flier, Ronald Boellaard, Sandeep Sv Golla, Bart Nm van Berckel

Abstract readComparative Study
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Substituting blood-based biomarkers for imaging measures in Alzheimer's disease studies: implications for sample size and bias.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Impact of simulated reduced injected dose on the assessment of amyloid PET scans.European journal of nuclear medicine and molecular imaging · 2024
    Article
  6. Test-retest performance of [Imaging neuroscience (Cambridge, Mass.) · 2024
    Article
  7. Performance of a [Neurology · 2023
    Article
  8. Article
  9. Article
  10. Precision estimates of relative and absolute cerebral blood flow in Alzheimer's disease and cognitively normal individuals.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  11. Longitudinal Tau PET UsingJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  12. The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  13. Article
  14. Article
  15. Clinical validity of increased cortical uptake of [European journal of nuclear medicine and molecular imaging · 2021
    Review
  16. Article
  17. Uses of Human MR and PET Imaging in Research of Neurodegenerative Brain Diseases.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tessa TimmersAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Rik OssenkoppeleAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Denise VisserDepartment of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Hayel TuncelDepartment of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Emma E WoltersAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Sander Cj VerfaillieDepartment of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.ORCID 0000-0003-1820-3378
Wiesje M van der FlierAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Ronald BoellaardDepartment of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Sandeep Sv GollaDepartment of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Bart Nm van BerckelDepartment of Radiology & Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the test-retest (TRT) repeatability of various parametric quantification methods for [

Indexed as

AgedAlzheimer DiseaseAmyloid beta-PeptidesBrainCarbolinesCognitionCognitive DysfunctionFemaleGray MatterHumansMaleMiddle AgedNeuropsychological TestsPositron-Emission TomographyRadiopharmaceuticalsReproducibility of Results7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indoleAmyloid beta-PeptidesCarbolinesRadiopharmaceuticalstau Proteins[18F]FlortaucipirAlzheimer’s diseaseparametric methodstest–retest repeatability

Identifiers

PMID31575335
PMCPMC7705644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.